Low Dose Amitriptyline-Induced Electrical Storm Unmasking a Novel SCN5A and KCNQ1 Compound Genotype: Insights from Family Cascade Screening
Cardiovascular Toxicology · 2026-05 · 26 (5)
DOI: 10.1007/s12012-026-10125-8 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cardiovascular Toxicology, online erschienen am 13.05.2026. Verfasst von Thai Duy Vo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Arrhythmology, Cho Ray Hospital, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: KCNQ1 Potassium Channel, NAV1.5 Voltage-Gated Sodium Channel, Amitriptyline, Ventricular Fibrillation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Cardiac toxicity from QT-prolonging drugs can precipitate malignant ventricular arrhythmias in susceptible individuals, and family screening may clarify inherited risk. We report a 33-year-old woman with a history of postpartum cardiac arrest treated with a secondary-prevention implantable cardioverter-defibrillator (ICD) who developed an electrical storm after self-administration of a single low dose of amitriptyline (12.5 mg). ICD interrogation documented 176 episodes of ventricular fibrillation requiring repeated shocks, followed by complete battery depletion, hemodynamic collapse, and the need for venoarterial extracorporeal membrane oxygenation and continuous renal replacement therapy. The admission electrocardiogram showed marked QT prolongation (QTc 651 ms), with previously documented prolonged baseline QTc values. Targeted next-generation sequencing identified a novel SCN5A missense variant (NM_000335.5:c.5738G > A) and a rare pathogenic KCNQ1 splice variant (NM_000218.3:c.1032G > C), cascade testing across the family demonstrated variable expressivity among carriers. Given a suspected contribution of late sodium current, a mechanism-based strategy was implemented with mexiletine added to propranolol and overdrive pacing (90 bpm). This case underscores the risk of malignant ventricular arrhythmias after exposure to QT-prolonging agents even at low doses, and supports genotype-informed, mechanism-based therapy to mitigate arrhythmic risk in patients with marked QT prolongation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Arrhythmology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.
- Can Tho University of Medicine, Can Tho City, Vietnam.
- Division of Cardiac Electrophysiology, Cardiovascular Center, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Medicine, HUTECH University, Ho Chi Minh City, Vietnam. dtt.binh@hutech.edu.vn.
Zitieren
APA
Vo, T. D., Kieu, N. D., Tran, L. U. P., Van Khanh Nguyen, T., Nguyen, T. T., Lo, L. W., & Dao, T. T. B. (2026). Low Dose Amitriptyline-Induced Electrical Storm Unmasking a Novel SCN5A and KCNQ1 Compound Genotype: Insights from Family Cascade Screening. Cardiovascular Toxicology, 26(5). https://doi.org/10.1007/s12012-026-10125-8
Vancouver
Vo TD, Kieu ND, Tran LUP, Van Khanh Nguyen T, Nguyen TT, Lo LW, et al. Low Dose Amitriptyline-Induced Electrical Storm Unmasking a Novel SCN5A and KCNQ1 Compound Genotype: Insights from Family Cascade Screening. Cardiovascular Toxicology. 2026;26(5). doi:10.1007/s12012-026-10125-8
BibTeX
@article{Vo2026,
author = {Vo, Thai Duy and Kieu, Ngoc Dung and Tran, Le Uyen Phuong and Van Khanh Nguyen, Thi and Nguyen, Tri Thuc and Lo, Li-Wei and Dao, Thi Thanh Binh},
title = {Low Dose Amitriptyline-Induced Electrical Storm Unmasking a Novel SCN5A and KCNQ1 Compound Genotype: Insights from Family Cascade Screening},
journal = {Cardiovascular Toxicology},
year = {2026},
volume = {26},
number = {5},
doi = {10.1007/s12012-026-10125-8}
}
EUVIMED